Eguinto, Alea Gail .

HRN: 20-54-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
CEFUROXIME 1.5GM (VIAL)
12/29/2022
01/04/2023
IVT
330mg
Q8
Pcap C
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: